Market closed·Syncing…
Market closed · Close · 19 Nov

Dr. Agarwal's Health Care Limited AGARWALEYEshare price and chart

Dr. Agarwal's Health Care closed at ₹553.10 on 19 November 2026, up 0.66% on the day. The 52-week range is ₹401.00 to ₹571.90.

₹553.10The price one share last traded at, in rupees.+0.66% · ₹3.63
52-wk low ₹40189% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹572

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on AGARWALEYE

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
69.2Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
63.5%Near average
today 63.5%20d avg 51%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+10.4%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+16.7%1 monthHow much the share price has changed over the period.+19.1%3 monthsHow much the share price has changed over the period.+10.2%1 yearHow much the share price has changed over the period.+5.4%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.27.8%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹17,535 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.102.4xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.8.3%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.7.84xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.15.2%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.28.5xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.09xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.3.4%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Hospital · 28 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.102.43vs 54.16 median
Cheapest: INDRAMEDCO 17.2Priciest: HCG 866.06
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.8.69%vs 10.24% median
Lowest: MAITREYA -7.51%Highest: KMCSHIL 17.52%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.31.44%vs 21.54% median
Lowest: SANGANI -44.94%Highest: GKSL 194.62%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 5 Nov 2026), sales rose 31.4% from a year earlier to ₹655 cr and profit rose 55.8% to ₹56.9 cr.

Also changed
  • Foreign institutions cut their holding by 9.7 points over 5 quarters (59.26% to 49.56%).
  • Domestic institutions raised their holding by 9.4 points over 5 quarters (6.44% to 15.87%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 8 results, the share rose on 4 and fell on 4, and moved by 3% or more on 4.

+8%
-8%
Q4 FY25Q3 FY26Q2 FY27

Q2 FY27: results filed 5 Nov 2026. The share went from its close on 4 Nov 2026 to its close on 6 Nov 2026 -1.37%.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
+10.3%over the last year
1 yr
+10.3%

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
32.33%promoter holding, as of 2026-09-30-0.1 pts since 2025
Promoter share since listing
2025-0232.33% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
32.3%
49.6%
15.9%
Promoter32.3%Foreign (FII)49.6%Domestic (DII)15.9%Public & others2.2%
Who is buying, who is leavingJun 25 to Sep 26
Promoter32.3%-0.1 pts
Foreign (FII)49.6%-9.7 pts
Domestic (DII)15.9%+9.4 pts

Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Amalgamation/Merger19-Nov-2026

Allotment of 1,51,90,373 Equity Shares of Dr. Agarwal s Health Care Limited pursuant to the Scheme of Amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited and their respective shareholders and creditors ( Scheme )

Agreements16-Nov-2026

Execution of Media Agreement by the Company with GoodEdge Advisory Private Limited

Analysts/Institutional Investor Meet/Con. Call Updates11-Nov-2026

Transcript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and half year ended September 30, 2026, at the analyst call held on November 05, 2026, is attached.

Analysts/Institutional Investor Meet/Con. Call Updates05-Nov-2026

Dr. Agarwal's Health Care Limited has informed the Exchange about Link of Recording

Monitoring Agency Report05-Nov-2026

Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended September 30, 2026, is attached.

Outcome of Board Meeting05-Nov-2026

Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted

ESOP/ESOS/ESPS05-Nov-2026

Allotment of 54,728 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022

Change in Management05-Nov-2026

Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company

Investor Presentation05-Nov-2026

Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation

Outcome of Board Meeting05-Nov-2026

Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Analysts/Institutional Investor Meet/Con. Call Updates23-Oct-2026

Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

ESOP/ESOS/ESPS20-Oct-2026

Allotment of 18,200 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022

Record Date20-Oct-2026

Dr. Agarwal's Health Care Limited has informed the Exchange that Record date for the purpose of Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited is 18-Nov-2026.

Outcome of Board Meeting20-Oct-2026

Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited and their respective shareholders and creditors

Certificate under SEBI (Depositories and Participants) Regulations, 201807-Oct-2026

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, is enclosed.

Backtest idea · AGARWALEYEMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYELower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYESupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on AGARWALEYE
Your own ideaWrite a rule for AGARWALEYE in plain English“Buy AGARWALEYE when …”
Start writing
Buy the dip on AGARWALEYEBuy when RSI(14) drops below 30
52-week high breakout on AGARWALEYEBuy when closes at a 52-week high
Golden cross on AGARWALEYEBuy when 50-day EMA crosses above 200-day
Stochastic oversold on AGARWALEYEBuy when stochastic %K drops below 20
Pullback in an uptrend on AGARWALEYEBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹17,535 cr
Larger than 71% of 28 peers
sector middle ₹4,337 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
102.4x
Higher than 82% of 22 peers
sector middle 54.2x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
7.8x
Higher than 81% of 26 peers
sector middle 5.5x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
8.3%
Lower than 78% of 18 peers
sector middle 12.3%
FY25 5.7%FY26 8.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
15.2%
Higher than 57% of 23 peers
sector middle 14.8%
FY25 12.4%FY26 15.2%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.09
Lower than 77% of 26 peers
sector middle 0.29
FY25 0.13FY26 0.07
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 46% of 28 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+31.4%
Higher than 64% of 22 peers
sector middle +21.5%

Peers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹10 Cr, after ₹448 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹519 Cr
Investing-₹308 Cr
Lenders and shareholders-₹220 Cr
Net change in cash-₹10 Cr
Operating cash per ₹100 of profit
₹327FY25₹309FY26
₹100 or more means the reported profit arrived as cash.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.5.7%8.3%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.12.4%15.2%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.13x0.07x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · AGARWALEYEStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYEPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYEBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYE52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on AGARWALEYE
Backtest idea · AGARWALEYEGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on AGARWALEYE
MACD momentum on AGARWALEYEBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on AGARWALEYEBuy when closes below the lower Bollinger band
Supertrend rider on AGARWALEYEBuy when supertrend turns up
Buy the dip on AGARWALEYEBuy when RSI(14) drops below 30
52-week high breakout on AGARWALEYEBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Hospital
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
APOLLOHOSP
Apollo Hospitals Enterprise Limited
1.26 L cr56.0x11.8x21.5%20.7%0.508.4%+20.8%0.23%
MAXHEALTH
Max Healthcare Institute Limited
1.01 L cr73.3x8.9x14.3%14.4%0.3315.1%+20.3%0.19%
MANIPALHOS
Manipal Health Enterprises Limited
91,609 cr-5.5x--0.34--0.00%
ASTERDM
Aster DM Quality Care Limited
64,443 cr102.1x8.3x10.1%14.8%0.438.7%+136.3%0.41%
FORTIS
Fortis Healthcare Limited
61,140 cr58.9x5.8x11.0%13.5%0.2910.7%+17.3%0.12%
MEDANTA
Global Health Limited
39,747 cr64.2x9.2x15.0%17.9%0.1612.1%+33.6%0.03%
NH
Narayana Hrudayalaya Ltd.
38,279 cr44.3x7.7x19.7%16.0%0.998.4%+73.0%0.24%
KIMS
Krishna Institute of Medical Sciences Limited
32,248 cr147.1x8.2x9.7%9.9%0.834.3%+39.9%0.00%
AGARWALEYE
Dr. Agarwal's Health Care Limited
17,535 cr102.4x7.8x8.3%15.2%0.098.7%+31.4%0.00%
RAINBOW
Rainbow Childrens Medicare Limited
12,602 cr43.1x7.3x17.9%27.8%0.0015.5%+23.2%0.28%
YATHARTH
Yatharth Hospital & Trauma Care Services Limited
10,392 cr54.5x5.5x9.9%12.4%0.2412.2%+54.4%0.05%
PARKHOSPS
Park Medi World Limited
10,240 cr36.8x4.7x13.0%17.7%0.2014.7%-0.00%
JLHL
Jupiter Life Line Hospitals Limited
9,219 cr49.3x5.7x13.7%16.0%0.3611.4%+16.0%0.07%
HCG
Healthcare Global Enterprises Limited
9,181 cr866.1x6.8x1.9%9.4%0.520.8%+13.1%0.00%
ARTEMISMED
Artemis Medicare Services Limited
5,370 cr46.8x5.4x11.6%14.8%0.2410.0%+13.2%0.13%
INDRAMEDCO
Indraprastha Medical Corporation Limited
3,303 cr17.2x4.1x27.5%37.7%0.0012.3%+8.3%1.11%
KMCSHIL
K M C Speciality Hospitals (India) Limited
3,288 cr53.8x----17.5%+24.1%0.00%
DRAGARWQ
Dr Agarwals Eye Hospital Limited
2,819 cr37.0x----15.3%+22.3%0.07%
SHALBY
Shalby Limited
1,317 cr34.3x1.3x3.5%6.7%0.533.2%+9.7%0.00%
GKSL
Gujarat Kidney And Super Speciality Limited
1,187 cr55.1x4.5x6.6%8.6%0.0616.2%+194.6%0.00%
GPTHEALTH
GPT Healthcare Limited
1,087 cr20.9x3.8x16.3%23.1%0.0510.2%+14.1%0.76%
UNIHEALTH
Unihealth Hospitals Limited
774 cr-7.5x-16.2%0.13--0.00%
MOMSBELIEF
Rays of Belief Limited
573 cr-3.8x--0.15--0.00%
LOTUSEYE
Lotus Eye Hospital and Institute Limited
213 cr444.6x3.5x0.1%1.2%0.290.8%+35.9%0.00%
NEPHROCARE
Nephro Care India Limited
149 cr-2.4x-8.7%0.00--0.00%
MAITREYA
Maitreya Medicare Limited
78 cr-2.8x--2.2%0.85-7.5%-0.1%0.00%
SANGANI
Sangani Hospitals Limited
76 cr22.0x1.9x-19.6%0.008.7%-44.9%0.00%
AATMAJ
Aatmaj Healthcare Limited
58 cr102.8x1.1x-3.6%0.451.9%+56.9%0.00%
ABH
ABH Healthcare Limited
44 cr-0.9x--0.80--0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-14.9
+4.4
-10.0
+9.5
+8.8
-1.1
-0.2
+7.4
-6.6
+6.2
+8.6
·
+8.8%
11m
2025
·
·
+11.2
-18.2
-7.2
+19.6
+12.9
-5.3
+17.3
-0.2
+5.4
-4.8
+26.8%
10m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-08-12HYPERION INVESTMENTS PTE. LTD. · bulkSELL2,41,60,000₹501.03₹1,210.49 Cr
2026-08-12CLAYMORE INVESTMENTS (MAURITIUS) PTE.LTD. · bulkSELL1,59,00,000₹501.54₹797.45 Cr
2026-08-12ICICI PRUDENTIAL MUTUAL FUND · bulkBUY62,11,813₹501.00₹311.21 Cr
2026-08-12POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND · bulkBUY36,26,410₹501.00₹181.68 Cr
2026-08-12INVESCO MUTUAL FUND · bulkBUY35,65,443₹504.64₹179.93 Cr
2026-08-12MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulkBUY19,59,808₹502.46₹98.47 Cr
2026-08-12ALLIANZ GLOBAL INVESTORS GMBH ACTING ON BEHALF OF ALLIANZ EEE FONDS · bulkBUY17,72,127₹501.00₹88.78 Cr
2026-08-12MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED · bulkSELL6,50,808₹510.96₹33.25 Cr
Annual reports

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test AGARWALEYE. “Buy AGARWALEYE when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free